Analysis-GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up By Reuters
By Michael Erman (Reuters) - U.S. sales of RSV vaccines from GSK and Pfizer (NYSE:) are down significantly after regulators...
By Michael Erman (Reuters) - U.S. sales of RSV vaccines from GSK and Pfizer (NYSE:) are down significantly after regulators...